lacosamide adroiq
extrovis eu ltd. - lakozamida - epilepsija - antiepileptici sredstva, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide accord
accord healthcare s.l.u. - lakozamida - epilepsija - antiepileptici sredstva, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide ucb
ucb pharma s.a. - lakozamida - epilepsije, djelomično - antiepileptici sredstva, - proizvođač УКБ prikazan kao monoterapija i dodatna terapija u liječenju parcijalnih napadaja napad sa ili bez sekundarne generalizacije kod odrasle, mlade i djecu od 4 godine s epilepsijom.
diclorapid 75 mg želučanootporne kapsule, tvrde
bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - diklofenaknatrij - želučanootporna kapsula, tvrda - 75 mg - urbroj: jedna tvrda želučanootporna kapsula sadrži 75 mg diklofenaknatrija
diclorapid 75 mg/1 kapsula gastrorezistentna kapsula, tvrda
pharmaswiss bh d.o.o. - diklofenak - gastrorezistentna kapsula, tvrda - 75 mg/1 kapsula - 1 gastrorezistentna kapsula, tvrda sadrži: 75 mg diklofenaknatrijuma
diclorapid 75 mg/1 kapsula gastrorezistentna kapsula, tvrda
amicus pharma d.o.o. - diklofenak - gastrorezistentna kapsula, tvrda - 75 mg/1 kapsula - 1 gastrorezistentna kapsula, tvrda sadrži: 75 mg diklofenaknatrijuma
diclorapid 75mg gastrorezistentna kapsula, tvrda
pharmaswiss - montenegro, pharmaswiss doo beograd, dio stranog druŠtva u podgorici - diklofenak - gastrorezistentna kapsula, tvrda - 75mg
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudin, Тенофовир дизопроксил фумарат - hiv infekcije - antivirusni lijekovi za liječenje hiv infekcija, kombinacija - delstrigo indiciran za liječenje odraslih osoba zaraženih hiv-1, bez prošlosti ili ovih dokaza otpornost do klase ННИОТ, lamivudin ili Тенофовир. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
holoxan 500 mg/1 viala prašak za rastvor za injekciju
co.medprom d.o.o. - ифосфамид - prašak za rastvor za injekciju - 500 mg/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 500 mg ifosfamid
holoxan 1000 mg/1 viala prašak za rastvor za injekciju
co.medprom d.o.o. - ифосфамид - prašak za rastvor za injekciju - 1000 mg/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 1000 mg ifosfamid